John MacKenzie chats with Associate Professor Severine Navarro, Team Head of Mucosal Immunology at QIMR Berghofer Medical Research Institute, about groundbreaking trials of a new treatment for asthma sufferers.
Mornings with John Mackenzie · Mornings with John Mackenzie
June 13, 20239m 27s
Show Notes
John MacKenzie chats with Associate Professor Severine Navarro, Team Head of Mucosal Immunology at QIMR Berghofer Medical Research Institute, about groundbreaking trials of a new treatment for asthma sufferers.
The QIMR Berghofer Institute is appealing for donations to help fast-track clinical trials for a new anti-inflammatory protein that can now be synthesised.
The protein is proving effective to treat asthma and could potentially work to treat a range of other conditions including hay fever, food allergies, and even coeliac.
The QIMR Berghofer Institute is appealing for donations to help fast-track clinical trials for a new anti-inflammatory protein that can now be synthesised.
The protein is proving effective to treat asthma and could potentially work to treat a range of other conditions including hay fever, food allergies, and even coeliac.